Retrospective Study
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. Sep 27, 2022; 14(9): 896-903
Published online Sep 27, 2022. doi: 10.4240/wjgs.v14.i9.896
Table 1 Demographic and clinical characteristics of the patients

Central pancreatectomy (n = 34)
Distal pancreatectomy (n = 262)
P value
Gender0.627
Female, n (%)25 (73.5)182 (69.5)
Male, n (%)9 (26.5)80 (30.5)
Age (x ± s, yr)48 ± 1352 ± 150.172
BMI (x ± s, kg/m2)22.4 ± 3.422.8 ± 3.60.545
Hypertension, n (%)7 (20.6)78 (29.8)0.266
Diabetes, n (%)2 (5.9)28 (10.7)0.568
Tumor size (x ± s, cm)3.2 ± 1.83.5 ± 2.10.433
Pathology, n (%)< 0.005
SCN13 (38.2)48 (18.3)
IPMN4 (11.8)47 (17.6)
MCN1 (2.9)50 (19.1)
SPN13 (38.2)52 (19.8)
pNET3 (8.8)50 (19.1)
Median distance between the tumor and left-side border of the SMV (mm)8.9 (10.9)12.5 (11.4)0.076
Table 2 Perioperative outcomes of the patients

Central pancreatectomy (n = 34)
Distal pancreatectomy (n = 262)
P value
Surgery, n (%)< 0.005
Open surgery25 (73.5)63 (24.2)
Laparoscopy9 (26.5)197 (75.8)
Associated splenectomy, n (%)0123 (46.9)
Mean operation time (min)311244< 0.05
Mean perioperative blood loss (mL)1591670.525
Overall morbidity, n (%)0.370
I13 (38.2)91 (34.0)
II11 (32.4)95 (36.6)
IIIa2 (5.9)17 (6.5)
IIIb2 (5.9)3 (1.1)
IV0 (0)0 (0)
POPF grade, n (%)0.073
A15 (44.1)67 (25.6)
B10 (29.4)85 (32.4)
C0 (0)0 (0)
Chyle leakage, n (%)1 (2.9)15 (5.7)0.926
Delayed gastric emptying, n (%)< 0.05
A9 (26.5)38 (14.5)
B1 (2.9)2 (0.8)
C0 (0)1 (0.4)
Postoperative bleeding0 (0)0 (0)-
Mean postoperative hospital stay (d)17110.783
In-hospital mortality0 (0)0 (0)-
Readmission within 30 d0 (0)0 (0)-
Table 3 Endocrine and exocrine function of the pancreas after surgery

Central pancreatectomy (n = 34)
Distal pancreatectomy (n = 262)
P value
Endocrine function
New-onset or aggravated diabetes mellitus, n (%)0 (0)40 (15.3)< 0.05
Exocrine function
Diarrhea immediately after surgery2 (5.9)46 (17.6)0.059
Diarrhea 12 mo after surgery0 (0)25 (9.5)< 0.05